pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Vera Therapeutics, Inc. ($VERA) · news · pharmadog
← back to Vera Therapeutics, Inc.
News mentioning $VERA
47
stories
3d
Vera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact
biospace
6d
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
biopharma dive
7d
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
biospace
7d
Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision
fiercebiotech
8d
Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines
biopharma dive
8d
Boulevard Bio dreams big in immunology with $65M, sights on Vera's IgAN drug
endpoints
8d
Boulevard starts up with $65M to pursue targeted autoimmune drugs
biopharma dive
9d
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
fiercebiotech
9d
Silence causes uproar in rare blood cancer space as data sets high bar for competitors
biospace
10d
Silence spells out Phase 2 success for gene-silencing drug in rare blood cancer
endpoints
10d
STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer
stat
10d
Silence brings the noise to Takeda with phase 2 blood cancer win
fiercebiotech
13d
Why Big Pharma is chasing the industry’s most-powerful supercomputer
biopharma dive
14d
Takeda’s narcolepsy nod opens orexin doors
biospace
16d
Vertex unfazed by competitive IgAN space as FDA verdict looms
biospace
20d
Federal government could improve infectious disease monitoring, says federal government
stat
20d
Syphilis spreads while researchers contend with federal constraints and a drug shortage
stat
22d
Incyte cuts early-stage cancer drug to focus on next-gen programs
biospace
Jul 21, 26
Agios axes next-gen sickle cell candidate after it fails to best Novo’s asset
biospace
Jul 21, 26
Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role
fiercebiotech
Jul 20, 26
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals
biospace
Jul 20, 26
BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’
fiercebiotech
Jul 14, 26
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
stat
Jul 13, 26
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
stat
Jul 13, 26
STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
stat
Jul 10, 26
STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more
stat
Jul 9, 26
STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and more
stat
Jul 9, 26
STAT+: The quest to save Grace — and clear the way for rare disease patients everywhere
stat
Jul 8, 26
STAT+: RFK Jr. plans to create list of injuries caused by Covid-19 vaccines
stat
Jul 8, 26
Bryan Johnson’s chronic disease is notoriously difficult to diagnose
stat
← prev
page 1 of 2
next →
